Market closedNon-fractional

Twist Bioscience/TWST

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Twist Bioscience

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Ticker

TWST

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

919

Twist Bioscience Metrics

BasicAdvanced
$2.8B
Market cap
-
P/E ratio
-$3.36
EPS
1.62
Beta
-
Dividend rate
$2.8B
1.62
5.51
4.896
13.355
15.965
-97,320.00%
-15.63%
-30.40%
9.79
4.93
6.54
-28.43
21.79%
-11.06%
34.91%
7.24%

What the Analysts think about Twist Bioscience

Analyst Ratings

Majority rating from 10 analysts.
Buy

Twist Bioscience Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-60.29% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$75M
5.46%
Net income
-$45M
5.58%
Profit margin
-60.29%
0.12%

Twist Bioscience Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.29%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
-$1.01
-$0.81
-$0.75
-$0.79
-
Expected
-$1.14
-$0.92
-$0.78
-$0.82
-$0.77
Surprise
-11.24%
-12.06%
-3.52%
-3.29%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Twist Bioscience stock?

Twist Bioscience (TWST) has a market cap of $2.8B as of July 04, 2024.

What is the P/E ratio for Twist Bioscience stock?

The price to earnings (P/E) ratio for Twist Bioscience (TWST) stock is 0 as of July 04, 2024.

Does Twist Bioscience stock pay dividends?

No, Twist Bioscience (TWST) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Twist Bioscience dividend payment date?

Twist Bioscience (TWST) stock does not pay dividends to its shareholders.

What is the beta indicator for Twist Bioscience?

Twist Bioscience (TWST) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Twist Bioscience stock

Buy or sell Twist Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing